Patrick Biché

Patrick Biché

Auto-generated profile, based on publicly available information

Patrick Biché

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2025 in medRxiv
Verified
Preprint
Open access
ASAdrienne E Shapiro
Adrienne E Shapiro
RDRonit R Dalmat
Ronit R Dalmat
JMJob Mukwatamundu
Job Mukwatamundu
CKCaleb Kamoga
Caleb Kamoga
MNM William Ngwane
M William Ngwane
Paul DrainPaul Drain
Paul Drain
Background: Molecular amplification of tongue swab samples is a non-sputum-based investigational approach to diagnose pulmonary tuberculosis (pTB). An improved manual qPCR method for tongue swabs recently achieved >90% sensitivity overall in diagnosing TB, compared to a sputum microbiologic reference standard. Performance characteristics in persons with low-positive results on sputum molecular tests are unknown. Methods: Adults in South Africa and Uganda with sputum Xpert MTB/RIF Ultra Trace (TR+) results were recruited for confirmatory evaluation and follow-up. They underwent symptom evaluation, examination, chest X-ray, further sputum testing (repeat Xpert Ultra and two solid and liquid mycobacterial cultures), and two tongue swabs. Tongue swabs were tested using qPCR amplification of the IS6110 gene. A single copy detected on >=1 swab was considered TB-positive. TR+ persons not diagnosed with TB at baseline were re-evaluated at 1 and 3 months. We determined the sensitivity and specificity of tongue swabs against TB culture alone, a microbiologic reference standard (MRS: any positive result from Xpert Ultra or TB culture) and a composite reference standard (CRS: a clinical recommendation for TB treatment or any positive culture) at baseline. Results: 225 enrolled TR+ participants (115 (51%) women, median age 38 [IQR 30-47], 130 (58%) people living with HIV (PWH)) provided at least 1 tongue swab at baseline. With a culture reference standard, 45 (20%) were positive for TB at baseline testing; 58 (26%) were positive for TB by MRS and 83 (37%) by CRS. Sensitivity and specificity of tongue swabs against culture were 25% [95% CI 13-40%] and 94% [90-97%], vs. MRS were 25% [95% CI 14-38%] and 96% [91-98%], and vs. CRS were 16% [9-26%] and 94% [89-98%]. Conclusion: Tongue swabs had low sensitivity and moderately high specificity for TB in persons with a Trace Xpert Ultra result. Tongue swabs have limited value for diagnosing people with low-positive molecular test results of uncertain clinical significance.

16 January 2026 in eClinicalMedicine
Verified
Journal Article
Open access
CHColleen F. Hanrahan
Colleen F. Hanrahan
BNBareng Aletta Sanny Nonyane
Bareng Aletta Sanny Nonyane
PBPatrick Biche
Patrick Biche
MMMbali Mohlamonyane
Mbali Mohlamonyane
MMMatshidiso Morolo
Matshidiso Morolo
DDDavid W. Dowdy
David W. Dowdy
One major challenge in the implementation of household contact investigation (HCI) for tuberculosis (TB) in high burden settings is finding contact persons in the home for screening. Conducting HCI during evenings, weekends, or holidays, particularly in settings with high levels of poverty, may improve effectiveness and implementation. We conducted a pragmatic, individually randomized controlled trial of HCI for TB at two sites in South Africa, comparing the effectiveness of two novel strategies for timing (during evenings and weekends in an urban area and during three annual holiday periods in a rural area) to weekday working hours. The primary outcome was the number of secondary cases identified and started on TB treatment per index participant, comparing novel versus standard timing at each site. Clinicaltrials.gov registration: NCT04520113. From September 2020 to August 2023, we randomized 1335 index participants with TB in Limpopo to receive standard HCI and 666 to receive holiday = based HCI, and 1616 to receive standard HCI and 805 to receive evening/weekend HCI in Soshanguve. In Limpopo, standard HCI and holidy-based HCI and resulted in 0.6 and 0.7 secondary TB diagnoses started on treatment per 100 index participants, respectively (difference: 0.1 [95% CI: −0.7, 0.8, p = 0.84]). In Soshanguve, evening/weekend-based HCI and standard HCI generated 0.4 and 0.6 diagnoses started on TB treatment per 100 index participants, respectively (difference 0.3 [95% CI: −0.8, 0.4, p = 0.54]). HCI conducted either during evenings/weekends or during holiday did not increase effectiveness compared to HCI conducted during weekday working hours. Funding was provided by the United States National Institute of Allergy and Infectious Diseases (Grant # 5R01AI147681).

3 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
PBPatrick Biché
Patrick Biché
FKFrancis Kayondo
Francis Kayondo
ANAnnet Nalutaaya
Annet Nalutaaya
JMJames Mukiibi
James Mukiibi
MNMariam Nantale
Mariam Nantale
EKEmily A Kendall
Emily A Kendall
Symptom-based tuberculosis (TB) screening often relies on cough reporting, which may be unreliable. Passive cough monitoring via smartphone apps offers a less subjective alternative. This study evaluated the diagnostic accuracy and implementation feasibility of smartphone-based cough frequency monitoring for identifying individuals likely to have TB in Uganda. We enrolled adults (≥15 years) screened for TB in community settings or tested at health facilities in Kampala. Participants underwent microbiological testing and 48-hour cough monitoring using the Hyfe Research app. TB status was determined using Xpert MTB/RIF Ultra and culture, and inverse probability weighting was applied to adjust for differential enrollment. We compared cough frequency between individuals with and without TB and assessed diagnostic accuracy using weighted ROC curves. We also conducted staff interviews, analyzed thematically, to explore implementation challenges. Of 884 enrolled participants, 197 had valid cough recordings and TB status (101 from community screening, 96 from health facilities). Individuals with TB had higher median cough frequency than those without: 2.2 (interquartile range 0.8-6.1) vs 0.9 (0.4-2.0) coughs per hour in the community and 6.7 (2.6-27.5) vs 2.4 (0.9-4.8) in facilities; Wilcoxon P < 0.0001 for both. AUCs for smartphone-based cough recording were 0.69 (95% CI: 0.58–0.79) in the community and 0.76 (95% CI: 0.6–0.88) in health facilities. At 90% sensitivity, specificities were 20% (95% CI: 0–22%) and 46% (95% CI: 1–32%), respectively. Smartphone-recorded cough frequency was moderately correlated with self-reported cough severity, respiratory-related quality of life scores (Saint George’s Respiratory Questionnaire), and staff-observed coughs. Staff cited device visibility, stigma, and security concerns as barriers to implementation. While smartphone-recorded cough frequency was associated with TB status, it did not meet diagnostic accuracy thresholds for stand-alone screening or triage. Implementation challenges also limited data collection. Addressing operational barriers will be critical to future development and deployment of cough monitoring tools for TB screening.

1 October 2026 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
PBPatrick Biché
Patrick Biché
FKFrancis Kayondo
Francis Kayondo
ANAnnet Nalutaaya
Annet Nalutaaya
JMJames Mukiibi
James Mukiibi
MNMariam Nantale
Mariam Nantale
EKEmily A. Kendall
Emily A. Kendall
Symptom-based tuberculosis screening usually depends on self-reported cough, which is subjective. Passive smartphone cough monitoring offers a more objective alternative. This study assessed the diagnostic accuracy and implementation feasibility of smartphone-based cough frequency monitoring for identifying likely TB cases in Uganda. Adults (≥15 years) screened in community settings or tested at Kampala health facilities underwent microbiological testing and 48 hours of cough monitoring with the Hyfe Research app. TB status was determined by Xpert MTB/RIF Ultra and culture, with inverse probability weighting to adjust for differential enrollment. Cough frequency was compared between participants with and without TB, and accuracy assessed using weighted ROC curves. Staff interviews, analyzed thematically, explored provider-side implementation challenges. Of 884 enrolled participants, 197 had both valid recordings and TB status (101 community, 96 facility). Median cough frequency was higher among those with TB: 2.2 coughs/hour (IQR 0.8–6.1) vs 0.9 (0.4–2.0) in the community, and 6.7 (2.6–27.5) vs 2.4 (0.9–4.8) in facilities (Wilcoxon P < 0.0001 for both). AUCs were 0.69 (95% CI 0.58–0.79) in the community and 0.76 (95% CI 0.60–0.88) in facilities. For self-reported cough at 90% sensitivity, specificities were 55% (95% CI 29–88%) and 36% (95% CI 17–68%), respectively. Recorded cough frequency correlated moderately with self-reported cough severity, Saint George’s Respiratory Questionnaire scores, and staff-observed coughs. Staff cited device visibility, stigma, and security concerns as barriers. Smartphone-recorded cough frequency was associated with TB status but did not meet accuracy thresholds for stand-alone screening or triage, and implementation problems limited data collection. Addressing these operational barriers will be critical to future development and deployment of cough monitoring tools for TB screening.

17 June 2026 in Clinical Infectious Diseases
Verified
Journal Article
Open access
GMGiridhar Mohan
Giridhar Mohan
CHColleen F Hanrahan
Colleen F Hanrahan
PMPablo Martinez-Amezcua
Pablo Martinez-Amezcua
CHChristopher J. Hoffmann
Christopher J. Hoffmann
PBPatrick Biché
Patrick Biché
DDDavid W Dowdy
David W Dowdy
Background: Household contact tracing (HHCT) is a widely recommended intervention for tuberculosis (TB) but is poorly implemented. Multidimensional poverty, encompassing deprivations in health, education, and living standards, may hinder implementation success. Methods: Using a cluster-randomized trial in South Africa, we examined the relationship between household multidimensional poverty as a composite deprivation score and HHCT reach as (1) initiation (at least one household contact screened); (2) continuous proportion of eligible household contacts screened; and (3) completion (all eligible household contacts screened once initiated). We performed multilevel mixed-effects modeling with modified Poisson and ordered beta regression. Results: Despite near-universal comfort with HHCT (97%) among 3392 households, only 43% initiated HHCT and 19% completed screening. Greater multidimensional poverty was significantly associated with lower HHCT initiation in urban households (adjusted prevalence ratio [aPR]: 0.903, 95% confidence interval [CI]: 0.831, 0.984, per 10% higher deprivation; P = .021), but not in rural households (aPR: 1.06, 95% CI: 0.99, 1.13; P = .083). Across all households, we observed a modest but statistically significant association between greater poverty and lower predicted proportion of household contacts screened (adjusted average marginal effect [aAME]: −1.22% [−2.20%, −0.236%], per 10% higher deprivation; P = .015). Among households that initiated HHCT, multidimensional poverty was not significantly associated with screening completion (aPR: 0.945, 95% CI: 0.865, 1.03; P = .207). Conclusions: Stated comfort with HHCT may not directly translate into implementation success. Multidimensional poverty was a significant structural barrier for HHCT initiation in an urban, South African township. Once initiated, getting all household contacts screened may require targeting additional operational and health system barriers.